These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15734925)

  • 1. Perfusion imaging of the liver: current challenges and future goals.
    Pandharipande PV; Krinsky GA; Rusinek H; Lee VS
    Radiology; 2005 Mar; 234(3):661-73. PubMed ID: 15734925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances of imaging for hepatocellular carcinoma.
    Choi BI
    Oncology; 2010 Jul; 78 Suppl 1():46-52. PubMed ID: 20616584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic portal perfusion using T2 measurements of Gd-DTPA.
    Uematsu H; Yamada H; Sadato N; Muramoto S; Inoue H; Hayashi K; Yonekura Y; Kimura H; Sakuma H; Matsuda T; Hayashi N; Yamamoto K; Ishii Y
    J Magn Reson Imaging; 1998; 8(3):650-4. PubMed ID: 9626881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic diagnosis of hepatocellular carcinoma.
    Ishiguchi T; Shimamoto K; Fukatsu H; Yamakawa K; Ishigaki T
    Semin Surg Oncol; 1996; 12(3):164-9. PubMed ID: 8727605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
    Baron RL; Peterson MS
    Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma: detection of tumor vascularity with duplex Doppler US.
    Bates SM; Keller MS; Ramos IM; Carter D; Taylor KJ
    Radiology; 1990 Aug; 176(2):505-7. PubMed ID: 2164236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the liver by helical CT and MR imaging.
    Yamashita Y; Morishita S; Awai K; Kawanaka K
    Intervirology; 2004; 47(3-5):125-33. PubMed ID: 15383721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.
    Shinmura R; Matsui O; Kobayashi S; Terayama N; Sanada J; Ueda K; Gabata T; Kadoya M; Miyayama S
    Radiology; 2005 Nov; 237(2):512-9. PubMed ID: 16244260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion-and diffusion-weighted imaging of hepatocellular carcinoma.
    Vandecaveye V; De Keyzer F; Dymarkowski S
    JBR-BTR; 2007; 90(6):492-6. PubMed ID: 18376763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypervascular hepatic focal lesions: spectrum of imaging features.
    Namasivayam S; Salman K; Mittal PK; Martin D; Small WC
    Curr Probl Diagn Radiol; 2007; 36(3):107-23. PubMed ID: 17484954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT and MRI of hepatocellular carcinoma: an update.
    Ayyappan AP; Jhaveri KS
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Rofsky NM; Diflo T; Teperman LW
    Radiology; 2001 May; 219(2):445-54. PubMed ID: 11323471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current practice in MR imaging of the liver].
    Kanematsu M; Kondo H; Matsuo M; Hoshi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Dec; 61(14):781-9. PubMed ID: 11828756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.